Product Code: ETC6184633 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Mastitis, a common issue in dairy cattle, presents both health and economic challenges in Australias agricultural sector. The market for mastitis-related products includes diagnostic tools, antibiotics, and preventive solutions. Government initiatives promoting sustainable farming practices and animal welfare support the adoption of mastitis control programs. Increased awareness and research into non-antibiotic treatments are shaping market trends.
Mastitis, commonly impacting dairy cattle, has implications for both animal health and milk production in Australia. Theres a growing trend towards precision farming and early disease detection using smart sensors and automation. In the human health context, increased awareness and education are driving early diagnosis and treatment, supported by telehealth services.
The mastitis market in Australia is heavily influenced by the dairy industry, and one of the key challenges lies in the underreporting of cases and reliance on traditional treatment methods. Many small-scale farmers may lack awareness or access to modern veterinary solutions. Antibiotic resistance and concerns around antibiotic residues in milk pose regulatory and consumer acceptance challenges. Moreover, the absence of widespread screening infrastructure makes early detection and proactive treatment difficult, prolonging the disease impact on livestock productivity.
Investors in the mastitis market can look toward agricultural technology companies that offer smart diagnostics, automated milking systems, and herd health monitoring platforms. Theres a growing niche in biotech firms developing mastitis prevention and treatment solutions, as well as R&D initiatives that support animal welfare and dairy productivity improvements.
In Australia, government policies focused on animal health, agriculture, and biosecurity play a crucial role in shaping the mastitis market. The Department of Agriculture, Water, and the Environment regulates the veterinary products used for mastitis treatment, ensuring that they meet the required standards for safety and efficacy. The Australian Pesticides and Veterinary Medicines Authority (APVMA) monitors the approval of drugs and treatments, and any changes to regulatory frameworks can affect the availability and cost of treatments for mastitis. Additionally, policies encouraging sustainable farming practices and welfare standards for dairy cattle directly influence how farmers approach mastitis management.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Mastitis Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Mastitis Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Mastitis Market - Industry Life Cycle |
3.4 Australia Mastitis Market - Porter's Five Forces |
3.5 Australia Mastitis Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Mastitis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Australia Mastitis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Australia Mastitis Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Australia Mastitis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Mastitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Mastitis Market Trends |
6 Australia Mastitis Market, By Types |
6.1 Australia Mastitis Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Mastitis Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Mastitis Market Revenues & Volume, By Infectious Mastitis, 2021- 2031F |
6.1.4 Australia Mastitis Market Revenues & Volume, By Non-Infectious Mastitis, 2021- 2031F |
6.2 Australia Mastitis Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Australia Mastitis Market Revenues & Volume, By Physical Examination, 2021- 2031F |
6.2.3 Australia Mastitis Market Revenues & Volume, By Milk Sample Examination, 2021- 2031F |
6.3 Australia Mastitis Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Australia Mastitis Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.3 Australia Mastitis Market Revenues & Volume, By Physical Therapy, 2021- 2031F |
6.4 Australia Mastitis Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Australia Mastitis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Mastitis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Australia Mastitis Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.4.5 Australia Mastitis Market Revenues & Volume, By Medication, 2021- 2031F |
6.4.6 Australia Mastitis Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.4.7 Australia Mastitis Market Revenues & Volume, By NSAIDs, 2021- 2031F |
6.5 Australia Mastitis Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Australia Mastitis Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 Australia Mastitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.4 Australia Mastitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.5 Australia Mastitis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Australia Mastitis Market Import-Export Trade Statistics |
7.1 Australia Mastitis Market Export to Major Countries |
7.2 Australia Mastitis Market Imports from Major Countries |
8 Australia Mastitis Market Key Performance Indicators |
9 Australia Mastitis Market - Opportunity Assessment |
9.1 Australia Mastitis Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Mastitis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Australia Mastitis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Australia Mastitis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Australia Mastitis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Mastitis Market - Competitive Landscape |
10.1 Australia Mastitis Market Revenue Share, By Companies, 2024 |
10.2 Australia Mastitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |